...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Spray-congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement
【24h】

Spray-congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement

机译:喷涂的固体脂质微粒作为来自磷酸钙骨水泥的双膦酸盐的控制释放的新工具

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstract Display Omitted Abstract The aim of this work was to develop an innovative drug delivery system potentially useful for the local delivery of Bisphosphonates to bone tissue. We propose the use of Solid Lipid Microparticles (MPs), up to now mainly used for oral and topical drug delivery, as carrier for bisphosphonates due to the favourable biocompatibility and lower toxicity of the lipids compared with many polymers. The delivery platform consisted of a biomimetic α-tricalcium phosphate-gelatin cement (CPC) enriched with alendronate loaded MPs (MPs-AL) produced by the spray congealing technology. Alendronate direct addition to cement composition is limited since Alendronate is able to sequester calcium from calcium phosphates, thus preventing the setting of the cements. At variance, this approach permitted to load a relatively high amount of the drug on the CPC and allowed the controlled release of the highly water soluble alendronate. A Design of Experiment (DoE) was employed for the screening of the effects of the formulation variables related to the presence of unloaded microparticle (MPs) on the cement most important mechanical properties. Then, MPs loaded with 10% w/w of alendronate were produced using five different carriers (Stearic Acid, Stearilic Alcohol, Cutina HR, Tristearin and Precirol ATO5). All MPs-AL exhibited a spherical shape, encapsulation efficiency higher than 90% and prevalent particle size ranging from 100 to 150μm. Solid state characterization (DSC, HSM and X-ray powder diffraction) demonstrated that encapsulation of alendronate into MPs did not alter its crystal structure. MPs-AL addition to the cement provoked a modest lengthening of the setting times and of the hardening reaction leading to the complete transformation of α-tricalcium phosphate into calcium-deficient hydroxyapatite, without significantly affect the cement mechanical properties. Moreover, the results of in vitro AL release study performed on cements enriched with MPs-AL showed that the system allows a controlled release of the drug over time.
机译:图形摘要显示省略了这项工作的目的是开发一种创新的药物输送系统,可能是对局部递送与骨组织的局部递送。我们提出使用固体脂质微粒(MPS),目前主要用于口服和局部药物递送,作为双膦酸盐的载体,由于与许多聚合物相比脂质的良好的生物相容性和较低的毒性。递送平台由富含生物氧化物α-β-磷酸钙 - 明胶水泥(CPC)组成,富含喷雾凝固技术生产的醛族负载的MPS(MPS-A1)。醛膦酸酯直接添加到水泥组合物中是受限制的,因为当醛酸克酸克酸甘蔗能够从磷酸钙中沉淀钙,从而防止水泥的设置。在方差中,这种方法允许在CPC上加载相对大量的药物,并允许高度水溶性的溶解释放的释放。实验(DOE)的设计用于筛选与卸载微粒(MPS)的存在相关的配方变量对水泥最重要的机械性能的影响。然后,使用五种不同的载体(硬脂酸,硬脂酸,Cutina HR,Tristearin和Precirol ATO5)生产装载10%w / w的MPS。所有MPS-AL都表现出球形,封装效率高于90%,普遍粒径为100至150μm。固态表征(DSC,HSM和X射线粉末衍射)证明了Alendronate封装到MPS中没有改变其晶体结构。 MPS-AL除了水泥引起的凝固时间和硬化反应的适度延长,导致α-磷酸钙的完全转化为钙缺乏羟基磷灰石,而不会显着影响水泥机械性能。此外,对富含MPS-A1富含水泥进行的体外Al释放研究的结果表明该系统允许随着时间的推移控制药物的控制释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号